Long ‐term follow‐up of ribavirin‐free DAA‐based treatment in HCV recurrence after orthotopic liver transplantation

ConclusionRBV‐free DAA combinations for the treatment of HCV recurrence after OLT are highly efficacious and well tolerated. Our long‐term data show that viral eradication is durable but not necessarily translated into beneficial long‐term clinical outcome.

Source: Liver International - January 31, 2018 Category: Gastroenterology Authors: Sandra Beinhardt, Ramona Al ‐Zoairy, Karin Kozbial, Albert F. Stättermayer, Andreas Maieron, Rudolf Stauber, Michael Strasser, Heinz Zoller, Ivo Graziadei, Susanne Rasoul‐Rockenschaub, Michael Trauner, Peter Ferenci, Harald Hofer Tags: ORIGINAL ARTICLE Source Type: research